Follow Us:
Join Our SLACK CommunitySignup for our newsletter
Thank you!
Biodesign Workshops

Needs Screening: Strategic Focus, Market and Stakeholder Analysis

June 21, 2018
6:00 pm
June 21, 2018
7:30 pm
TMCx Accelerator
TMCx Accelerator

Workshop Summary

Building on our needs brainstorm cases from last time, we will discuss forming a comprehensive needs statement and determining what makes a "good need". We'll learn to screen our long list of needs to identify ones that could create the most value for all stakeholders. We will spend most of the time working in small groups with mentors to give you hands-on experience with actual cases.

Doors open at 5:30pm for networking, food, and drinks. Class starts at 6pm sharp!


Biodesign workshops are designed to provide new entrepreneurs with an understanding of the innovation process, teaching them how to evaluate a life science technology as the basis for starting a new business. Learn how you can turn your creativity loose to design the future of healthcare. Whether you're an engineer, scientist, physician, or business expert, this class will bring you up to speed on the medical innovation process.

This series of workshops hosted by Enventure once a month will provide trainees with the opportunity to gain skills that you won't learn in the lab. We will be focusing on developing technologies that create value for patients, caregivers, and society using Stanford's Biodesign medical innovation process.

Topics will include: Idea Viability, Market analysis, IP and Licensing, Building a Business Plan, and more. Series begins May 17. Attendance at each workshop is required for certificate, but the course is available to everyone for free.

Will Clifton, MD
President & Co-founder, Enventure

SHORTEN BIO Will Clifton, MD, is a life science entrepreneur and bioengineer with a background in medical devices and innovation. After earning his MD, Dr. Clifton served as Senior Director of Medical Affairs at Procyrion, where he spent seven years developing a minimally invasive pump to treat heart failure, taking it from concept through a successful first in human trial.